BBC Russian
Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


Slime-producing staphylococci frequently colonize catheters, and when they are embedded in biofilm, they become resistant to various antibiotics. In the study that is described, the comparative efficacies of vancomycin, clindamycin, novobiocin, and minocycline, alone or in combination with rifampin, were tested in an in vitro model of colonization. The model consisted of the modified Robbins device with antibiotic-impregnated cement filling the lumen of catheter segments. The synergistic combination of minocycline and rifampin was the most efficacious in preventing bacterial colonization of slime-producing strains of Staphylococcus epidermidis and Staphylococcus aureus to catheter surfaces. A similar trend was observed when the inhibitory activities of polyurethane catheters coated with minocycline and rifampin were compared with the inhibitory activities of catheters coated with other antimicrobial agents. The inhibitory activities of catheters coated with minocycline and rifampin against S. epidermidis, S. aureus, and Enterococcus faecalis strains, for example, were significantly better than those of catheters coated with vancomycin (P < 0.05). The inhibitory activities of catheters coated with minocycline and rifampin against gram-negative bacilli and Candida albicans were comparable to those of catheters coated with ceftazidime and amphotericin B, respectively. We found that the combination of minocycline and rifampin is unique and highly effective in preventing the colonization of catheters with slime-producing staphylococci and that it also displays a broad-spectrum inhibitory activity against gram-negative bacteria and yeast cells.

Free full text 


Logo of aacLink to Publisher's site
Antimicrob Agents Chemother. 1995 Nov; 39(11): 2397–2400.
PMCID: PMC162954
PMID: 8585715

Antibiotics and prevention of microbial colonization of catheters.

Abstract

Slime-producing staphylococci frequently colonize catheters, and when they are embedded in biofilm, they become resistant to various antibiotics. In the study that is described, the comparative efficacies of vancomycin, clindamycin, novobiocin, and minocycline, alone or in combination with rifampin, were tested in an in vitro model of colonization. The model consisted of the modified Robbins device with antibiotic-impregnated cement filling the lumen of catheter segments. The synergistic combination of minocycline and rifampin was the most efficacious in preventing bacterial colonization of slime-producing strains of Staphylococcus epidermidis and Staphylococcus aureus to catheter surfaces. A similar trend was observed when the inhibitory activities of polyurethane catheters coated with minocycline and rifampin were compared with the inhibitory activities of catheters coated with other antimicrobial agents. The inhibitory activities of catheters coated with minocycline and rifampin against S. epidermidis, S. aureus, and Enterococcus faecalis strains, for example, were significantly better than those of catheters coated with vancomycin (P < 0.05). The inhibitory activities of catheters coated with minocycline and rifampin against gram-negative bacilli and Candida albicans were comparable to those of catheters coated with ceftazidime and amphotericin B, respectively. We found that the combination of minocycline and rifampin is unique and highly effective in preventing the colonization of catheters with slime-producing staphylococci and that it also displays a broad-spectrum inhibitory activity against gram-negative bacteria and yeast cells.

Full Text

The Full Text of this article is available as a PDF (369K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun. 1982 Jul;37(1):318–326. [Europe PMC free article] [Abstract] [Google Scholar]
  • Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985 Dec;22(6):996–1006. [Europe PMC free article] [Abstract] [Google Scholar]
  • Clumeck N, Marcelis L, Amiri-Lamraski MH, Gordts B. Treatment of severe staphylococcal infections with a rifampicin-minocycline association. J Antimicrob Chemother. 1984 Jun;13 (Suppl 100):17–22. [Abstract] [Google Scholar]
  • Darouiche R, Wright C, Hamill R, Koza M, Lewis D, Markowski J. Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin. Antimicrob Agents Chemother. 1991 Aug;35(8):1612–1615. [Europe PMC free article] [Abstract] [Google Scholar]
  • Darouiche RO, Dhir A, Miller AJ, Landon GC, Raad II, Musher DM. Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis. 1994 Sep;170(3):720–723. [Abstract] [Google Scholar]
  • Eppes SC, Troutman JL, Gutman LT. Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatr Infect Dis J. 1989 Feb;8(2):99–104. [Abstract] [Google Scholar]
  • Evans RC, Holmes CJ. Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer. Antimicrob Agents Chemother. 1987 Jun;31(6):889–894. [Europe PMC free article] [Abstract] [Google Scholar]
  • Farber BF, Kaplan MH, Clogston AG. Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis. 1990 Jan;161(1):37–40. [Abstract] [Google Scholar]
  • Graybill JR, Ahrens J. Interaction of rifampin with other antifungal agents in experimental murine candidiasis. Rev Infect Dis. 1983 Jul-Aug;5 (Suppl 3):S620–S625. [Abstract] [Google Scholar]
  • Hampton AA, Sherertz RJ. Vascular-access infections in hospitalized patients. Surg Clin North Am. 1988 Feb;68(1):57–71. [Abstract] [Google Scholar]
  • Khardori N, Wong E, Nguyen H, Jeffery-Wiseman C, Wallin E, Tewari RP, Bodey GP. Effect of subinhibitory concentrations of clindamycin and trospectomycin on the adherence of Staphylococcus epidermidis in an in vitro model of vascular catheter colonization. J Infect Dis. 1991 Jul;164(1):108–113. [Abstract] [Google Scholar]
  • Kiehn TE, Armstrong D. Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices. Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):869–872. [Abstract] [Google Scholar]
  • Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977 Jun 9;296(23):1305–1309. [Abstract] [Google Scholar]
  • Mandell GL. The antimicrobial activity of rifampin: emphasis on the relation to phagocytes. Rev Infect Dis. 1983 Jul-Aug;5 (Suppl 3):S463–S467. [Abstract] [Google Scholar]
  • Minuth JN, Holmes TM, Musher DM. Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci. Antimicrob Agents Chemother. 1974 Oct;6(4):411–414. [Europe PMC free article] [Abstract] [Google Scholar]
  • Norwood S, Ruby A, Civetta J, Cortes V. Catheter-related infections and associated septicemia. Chest. 1991 Apr;99(4):968–975. [Abstract] [Google Scholar]
  • Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, Washburn RG, Scheld WM, Karchmer AW, Dine AP, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med. 1994 Nov 17;331(20):1325–1330. [Abstract] [Google Scholar]
  • Sande MA. The use of rifampin in the treatment of nontuberculous infections: an overview. Rev Infect Dis. 1983 Jul-Aug;5 (Suppl 3):S399–S401. [Abstract] [Google Scholar]
  • Segreti J, Gvazdinskas LC, Trenholme GM. In vitro activity of minocycline and rifampin against staphylococci. Diagn Microbiol Infect Dis. 1989 May-Jun;12(3):253–255. [Abstract] [Google Scholar]
  • Sherertz RJ, Carruth WA, Hampton AA, Byron MP, Solomon DD. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis. 1993 Jan;167(1):98–106. [Abstract] [Google Scholar]
  • Sherertz RJ, Forman DM, Solomon DD. Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice. Antimicrob Agents Chemother. 1989 Aug;33(8):1174–1178. [Europe PMC free article] [Abstract] [Google Scholar]
  • Sherertz RJ, Raad II, Belani A, Koo LC, Rand KH, Pickett DL, Straub SA, Fauerbach LL. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol. 1990 Jan;28(1):76–82. [Europe PMC free article] [Abstract] [Google Scholar]
  • Trippel SB. Antibiotic-impregnated cement in total joint arthroplasty. J Bone Joint Surg Am. 1986 Oct;68(8):1297–1302. [Abstract] [Google Scholar]
  • Waterworth PM. The effect of minocycline on Candida albicans. J Clin Pathol. 1974 Apr;27(4):269–272. [Europe PMC free article] [Abstract] [Google Scholar]
  • Yourassowsky E, van der Linden MP, Lismont MJ, Crokaert F. Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus. J Clin Pathol. 1981 May;34(5):559–563. [Europe PMC free article] [Abstract] [Google Scholar]
  • Yuk JH, Dignani MC, Harris RL, Bradshaw MW, Williams TW., Jr Minocycline as an alternative antistaphylococcal agent. Rev Infect Dis. 1991 Sep-Oct;13(5):1023–1024. [Abstract] [Google Scholar]
  • Zimmerli W, Frei R, Widmer AF, Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother. 1994 May;33(5):959–967. [Abstract] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

Citations & impact 


Impact metrics

Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/3351893
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/3351893

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1128/aac.39.11.2397

Supporting
Mentioning
Contrasting
3
106
1

Article citations


Go to all (112) article citations

Other citations

Similar Articles 


To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.